Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Warts 12Keratosis, Actinic 12Breast Neoplasms 11Prostatic Neoplasms 10Uterine Cervical Dysplasia 7Retinoblastoma 7Peripheral Nervous System Diseases 6Pain 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Stomatitis 4Esophageal Neoplasms 4Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Mucositis 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Stomach Neoplasms 2Papillomavirus Infections 2Multiple Myeloma 2Mesothelioma 2Melanoma 2Keratosis 2Deglutition Disorders 2Condylomata Acuminata 2Carcinoma, Ductal, Breast 2Carcinoma, Basal Cell 2Bone Neoplasms 2Barrett Esophagus 2

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 135Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 67fludarabine phosphate 61Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Cisplatin 36CTLA-4 Antigen 36Carboplatin 35cobimetinib 34Specimen Handling 34Magnetic Resonance Spectroscopy 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Melanoma × Cryotherapy × Clear all
NCT03949153 2025-10-01

CRIRIN

University Hospital, Strasbourg, France

Phase 1/2 Completed
19 enrolled
Dermatologic

Melanoma

NCT05302921 2025-01-01

Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors

Children's National Research Institute

Phase 2 Completed
5 enrolled
CNSDermatologicGastrointestinalGenitourinarySarcoma

Carcinoma, Hepatocellular, Melanoma, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡